Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.089 | 0.8 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |